Sign in Create account

Rainbow Childrens Medicare Limited

Healthcare · Healthcare Services

NSE: RAINBOW BSE: 543524
₹1314.30
▼ -53.50 (-3.91%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
63/100
Moderate
Valuation
—/100
Expensive
Momentum
25/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹13,348 Cr
PE (TTM)
53.1
Industry median 50.2 (44 companies)
Price to Book
8.0
PEG (TTM)
262.3
Institutions holding %
38.59%
FII + DII, latest filed period
Piotroski Score
4
Relative return vs Nifty50, qtr %
-2.3
Relative return vs Sector, qtr %
-4.8
Free Cash Flow
₹203 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
2.16%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
0.17%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
9.99%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
1.91%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
22.64%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
3.59
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
5.58
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
12.84%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
21.87%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
25.23%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
10.15%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
16.83%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
16.92%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

4 of 8 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 4)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (16.9%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

4 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-3.9%
Low 1305.1000 · High 1383.0000
1W return
-6.6%
Low 1305.1000 · High 1422.3000
1M return
-7.1%
Low 1305.1000 · High 1505.0000
52W return
-2.2%
Low 1084.0000 · High 1610.0000
Lifetime High ₹1677.2500 (Dec. 4, 2024)
Lifetime Low ₹420.3000 (June 20, 2022)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
1362.7
10D
1389.8
20D
1415.4
50D
1435.7
100D
1413.3
200D
1331.2

Delivery and volume

Day avg. delivery
60.4%
Week avg. delivery
67.4%
Month avg. delivery
64.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1334.13
Pivot
First resistance1363.17
Second resistance1412.03
Third resistance1441.07
First support1285.27
Second support1256.23
Third support1207.37
Day RSI24.5
Day MFI25.2
Day MACD-27.32
Day MACD signal-15.75

Beta

1M-0.36
3M0.24
1Y0.50
3Y0.37

Price change analysis

↓ -7.1%
Over 1 Month
LowHigh
1305.101505.00
↓ -7.6%
Over 3 Months
LowHigh
1305.101610.00
↑ 11.8%
Over 6 Months
LowHigh
1120.501610.00
↓ -2.2%
Over 1 Year
LowHigh
1084.001610.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 53.1 (own history: 47.2–65.2)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹411 Cr
Net profit (June 30, 2026)
₹53 Cr
Basic EPS (June 30, 2026)
₹5.2000

Ranks #13 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter49.84%
  • Mutual funds18.53%
  • FII/FPI16.03%
  • Other DII4.03%
  • Public11.39%

Largest holders

NameCategoryShares %Shares
RAMESH KANCHARLAPromoter31.0300%31517431
CHIRLA DINESH KUMAR PADMARAOPromoter6.5300%6633310
ADARSH KANCHARLAPromoter6.0200%6110432
ICICI PRUDENTIAL ESG EXCLUSIONARY STRATEGY FUNDPublic5.9800%6070842
RAMESH KANCHARLA (KANCHARLA FAMILY TRUST)Promoter5.1300%5205700

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 49.84% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 17.24% to 16.03% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 17.46% to 18.53% in Jun 2026 qtr

40 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 36 insider trades, 6 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
6 Nov 2024 Dr. Prashanth K Employee / designated person Sell 0 ₹0
6 Nov 2024 Dr. Pranathi Subrahmanyam Maddirala Employee / designated person Sell 0 ₹0
30 Sep 2024 Dr. Pranathi Subrahmanyam Maddirala Employee / designated person Sell 0 ₹0
20 Sep 2024 Dr. Preetham Kumar Poddutoor Employee / designated person Sell 0 ₹0
19 Sep 2024 Dr. Shruthi Reddy Poddutoor Employee / designated person Sell 0 ₹0
19 Sep 2024 Dr. Preetham Kumar Poddutoor Employee / designated person Sell 0 ₹0
17 Sep 2024 Dr. Pranathi Subrahmanyam Maddirala Employee / designated person Sell 0 ₹0
28 Aug 2024 Vikas Maheshwari Key managerial personnel Buy 0 ₹0
21 Aug 2024 Dr. Pranathi Subrahmanyam Maddirala Employee / designated person Sell 0 ₹0
21 Aug 2024 Dr. Preetham Kumar Poddutoor Employee / designated person Sell 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 2 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
5 Dec 2022 CDC GROUP PLC Bulk Sell 9,632,876 735.5500 NSE
5 Dec 2022 ABU DHABI INVESTMENT AUTHORITY Bulk Buy 900,000 741.2500 NSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹3.50 per share
Dividend yield 0.27%
Ex-dateSubjectPer share (₹)Record date
21 Jul 2026 Dividend - Rs 3.50 Per Share 3.5000 21 Jul 2026
27 Jun 2025 Dividend - Rs 3 Per Share 3.0000 28 Jun 2025
23 Jul 2024 Annual General Meeting/Dividend - Rs 3 Per Share 3.0000 23 Jul 2024
22 Jun 2023 Annual General Meeting/Dividend - Rs 3 Per Share 3.0000 22 Jun 2023
7 Sep 2022 Annual General Meeting/Dividend - Rs 2 Per Share 2.0000 8 Sep 2022

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
30 Jul 2026 Financial Results/Other business matters Yes
23 May 2026 Financial Results/Dividend/Other business matters Yes
28 Jan 2026 Financial Results Yes
13 Nov 2025 Financial Results Yes
26 Jul 2025 Financial Results Yes

Corporate Announcements

All 408 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Company Update Rainbow Children's Medicare Ltd - 543524 - Intimation Of Execution Of Lease Agreement With APCRDA For Development Of A Children'S Hospital At Amravati, Andhra Pradesh.
30 Sep 2026 Updates Rainbow Childrens Medicare Limited has informed the Exchange regarding 'execution of lease agreement with APCRDA for development of a children s hospital at Amravati, Andhra Pradesh'.
29 Sep 2026 Credit Rating Rainbow Childrens Medicare Limited has informed the Exchange about Credit Rating
29 Sep 2026 Company Update Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Credit Rating
25 Sep 2026 Insider Trading / SAST Rainbow Children's Medicare Ltd - 543524 - Closure of Trading Window
25 Sep 2026 Trading Window Rainbow Childrens Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
23 Sep 2026 Appointment Rainbow Childrens Medicare Limited has informed the Exchange regarding Appointment of Mr Sudarshan Patodia as Chief Financial Officer of the company w.e.f. September 23, 2026.
23 Sep 2026 Options to purchase securities Rainbow Childrens Medicare Limited has informed the Exchange about the grant of options
23 Sep 2026 Updates Rainbow Childrens Medicare Limited has informed the Exchange regarding 'Intimation of Contact Details of Key Managerial Personnel authorised under Regulation 30(5) of SEBI (LODR) Regulations, 2015'.
23 Sep 2026 Outcome of Board Meeting Rainbow Childrens Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on September 23, 2026.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Strong revenue growth YoY (22.6%)

Weaknesses

Data unavailable.

Opportunities

  • RSI in oversold territory (24.5) -- a technical rebound zone

Threats

  • PE above 35 (53.1) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Part of: NIFTY 500, NIFTY 500

Frequently asked questions about Rainbow Childrens Medicare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.